Evidence map›Paper›PMID 34154953›Full record

Observational studyArchives of cardiovascular diseases2021

Characteristics and outcomes of patients hospitalized for COVID-19 in France: The Critical COVID-19 France (CCF) study.

Guillaume Bonnet, Orianne Weizman, Antonin Trimaille, Thibaut Pommier, Joffrey Cellier, Laura Geneste, Vassili Panagides, Wassima Marsou, Antoine Deney, Sabir Attou and 27 more

Abstract readComparative StudyMulticenter StudyObservational Study
In one paragraph

Observational study in Archives of cardiovascular diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. The association between stroke and COVID-19-related mortality: a systematic review and meta-analysis based on adjusted effect estimates.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022
    Pooled it
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Review
  15. Observational
  16. Predictive risk factors for hospitalization and response to colchicine in patients with COVID-19.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  17. Cardiovascular System during SARS-CoV-2 Infection.International journal of environmental research and public health · 2022
    Review
  18. Article
  19. Cardiovascular Characteristics and Outcomes of Young Patients with COVID-19.Journal of cardiovascular development and disease · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Guillaume BonnetUniversité de Paris, PARCC, inserm, 75015 Paris, France; Hôpital Européen Georges-Pompidou, Université de Paris, 75015 Paris, France.
Orianne WeizmanUniversité de Paris, PARCC, inserm, 75015 Paris, France; Centre Hospitalier Régional Universitaire de Nancy, 54511 Vandoeuvre-Les-Nancy, France.
Antonin TrimailleNouvel hopital Civil, Centre Hospitalier régional universitaire de Strasbourg, 67000 Strasbourg, France.
Thibaut PommierLariboisiere hospital, AP-HP, university of Paris, 75010 Paris, France; Centre Hospitalier Universitaire de Dijon, 21000 Dijon, France.
Joffrey CellierHôpital Européen Georges-Pompidou, Université de Paris, 75015 Paris, France.
Laura GenesteCentre Hospitalier universitaire d'Amiens-Picardie, 80000 Amiens, France.
Vassili PanagidesCentre Hospitalier Universitaire de Marseille, 13005 Marseille, France.
Wassima MarsouGCS-Groupement des Hôpitaux de l'Institut Catholique de Lille, Faculté de Médecine et de Maïeutique, Université Catholique de Lille, Lille, France.
Antoine DeneyCentre Hospitalier universitaire de Toulouse, 31400 Toulouse, France.
Sabir AttouCentre Hospitalier universitaire de Caen-Normandie, 14000 Caen, France.
Thomas DelmotteCentre Hospitalier universitaire de Reims, 51100 Reims, France.
Sophie RibeyrollesInstitut mutualiste Montsouris, 75014 Paris, France.
Pascale ChemalyInstitut Cardiovasculaire Paris Sud, 91300 Massy, France.
Clément KarsentyCentre Hospitalier universitaire de Toulouse, 31400 Toulouse, France.
Gauthier GiordanoCentre Hospitalier Régional Universitaire de Nancy, 54511 Vandoeuvre-Les-Nancy, France.
Alexandre GautierInstitut Cardiovasculaire Paris Sud, 91300 Massy, France.
Corentin ChaumontRouen University Hospital, FHU REMOD-VHF, 76000 Rouen, France.
Pierre GuilleminotCentre Hospitalier Universitaire de Dijon, 21000 Dijon, France.
Audrey SagnardCentre Hospitalier Universitaire de Dijon, 21000 Dijon, France.
Julie PastieroCentre Hospitalier Universitaire de Dijon, 21000 Dijon, France.
Nacim EzzouhairiCentre Hospitalier universitaire de Bordeaux, 33076 Bordeaux, France.
Benjamin PerinCentre Hospitalier Régional Universitaire de Nancy, 54511 Vandoeuvre-Les-Nancy, France.
Cyril ZakineClinique Saint-Gatien, 37540 Saint-Cyr-sur-Loire, France.
Thomas LevasseurCentre Hospitalier intercommunal Fréjus-Saint-Raphaël, 83600 Fréjus, France.
Iris MaHôpital Européen Georges-Pompidou, Université de Paris, 75015 Paris, France.
Diane ChavignierCentre Hospitalier régional de Orléans, 45100 Orléans, France.
Nathalie NoirclercCentre Hospitalier Annecy Genevois, 74370 Epagny Metz-Tessy, France.
Arthur DarmonHôpital Bichat-Claude-Bernard, AP-HP, université de Paris, 75018 Paris, France.
Marine MevelecCentre Hospitalier régional de Orléans, 45100 Orléans, France.
Baptiste DuceauUniversité de Paris, PARCC, inserm, 75015 Paris, France; Centre Hospitalier Régional Universitaire de Nancy, 54511 Vandoeuvre-Les-Nancy, France.
Willy SutterUniversité de Paris, PARCC, inserm, 75015 Paris, France; Centre Hospitalier Régional Universitaire de Nancy, 54511 Vandoeuvre-Les-Nancy, France.
Delphine MikaUniversité Paris-Saclay, Inserm, UMR-S 1180, 92296 Chatenay-Malabry, France.
Charles FauvelRouen University Hospital, FHU REMOD-VHF, 76000 Rouen, France.
Théo PezelLariboisiere hospital, AP-HP, university of Paris, 75010 Paris, France.
Victor WaldmannUniversité de Paris, PARCC, inserm, 75015 Paris, France; Hôpital Européen Georges-Pompidou, Université de Paris, 75015 Paris, France.
Ariel CohenHôpital Saint-Antoine, Saint-Antoine and Tenon hospitals, AP-HP, Inserm UMRS-ICAN 1166 Sorbonne-Université, French Society of Cardiology 2020-2022, 184, rue du Faubourg Saint-Antoine, 75012 Paris, France. Electronic address: ariel.cohen@aphp.fr.
Critical COVID-19 France Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe coronavirus disease 2019 (COVID-19) pandemic has led to a public health crisis. Only limited data are available on the characteristics and outcomes of patients hospitalized for COVID-19 in France.

aimsTo investigate the characteristics, cardiovascular complications and outcomes of patients hospitalized for COVID-19 in France.

methodsThe Critical COVID-19 France (CCF) study is a French nationwide study including all consecutive adults with a diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection hospitalized in 24 centres between 26 February and 20 April 2020. Patients admitted directly to intensive care were excluded. Clinical, biological and imaging parameters were systematically collected at hospital admission. The primary outcome was in-hospital death.

resultsOf 2878 patients included (mean±SD age 66.6±17.0 years, 57.8% men), 360 (12.5%) died in the hospital setting, of which 7 (20.7%) were transferred to intensive care before death. The majority of patients had at least one (72.6%) or two (41.6%) cardiovascular risk factors, mostly hypertension (50.8%), obesity (30.3%), dyslipidaemia (28.0%) and diabetes (23.7%). In multivariable analysis, older age (hazard ratio [HR] 1.05, 95% confidence interval [CI] 1.03-1.06; P<0.001), male sex (HR 1.69, 95% CI 1.11-2.57; P=0.01), diabetes (HR 1.72, 95% CI 1.12-2.63; P=0.01), chronic kidney failure (HR 1.57, 95% CI 1.02-2.41; P=0.04), elevated troponin (HR 1.66, 95% CI 1.11-2.49; P=0.01), elevated B-type natriuretic peptide or N-terminal pro-B-type natriuretic peptide (HR 1.69, 95% CI 1.0004-2.86; P=0.049) and quick Sequential Organ Failure Assessment score ≥2 (HR 1.71, 95% CI 1.12-2.60; P=0.01) were independently associated with in-hospital death.

conclusionsIn this large nationwide cohort of patients hospitalized for COVID-19 in France, cardiovascular comorbidities and risk factors were associated with a substantial morbi-mortality burden.

Indexed as

PandemicsSARS-CoV-2AdultAgedAged, 80 and overCardiovascular DiseasesComorbidityCOVID-19Diabetes MellitusDyslipidemiasFemaleFranceHospital MortalityHumansHypertensionInpatientsCaractéristiquesCardiovascular risk factorsCharacteristicsCOVID-19DeathDécèsFacteurs de risque cardiovasculaireSARS-CoV-2

Identifiers

PMID34154953
PMCPMC7923854

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.